C. Robert Horsburgh, MD

Professor, Epidemiology

C. Horsburgh
617.358.3758
715 Albany St Talbot Building

Biography

Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Department of Biostatistics, the Department of GLobal Health and the Department of Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS and the Epidemiology of Tuberculosis. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, Peru, South Africa and Tanzania. He has served as the National Steering Committee Co-Chairman of the Tuberculosis Trials Consortium and the Tuberculosis Epidemiologic Studies Consortium. He is currently the Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials (www.resisttb.org). His office is located in the Center for Global Health and Development at BU School of Public Health.

Other Positions

  • Professor, Global Health, Boston University School of Public Health
  • Professor, Infectious Diseases, Medicine, Boston University School of Medicine
  • Professor, Biostatistics, Boston University School of Public Health
  • Boston Medical Center

Education

  • Case Western Reserve University, MD
  • Yale University, MS
  • Princeton University, AB

Publications

  • Published on 5/8/2019

    Martinez L, Lo NC, Cords O, Hill PC, Khan P, Hatherill M, Mandalakas A, Kay A, Croda J, Horsburgh CR, Zar HJ, Andrews JR. Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies. Lancet Respir Med. 2019 Jun; 7(6):544-552. PMID: 31078497.

    Read at: PubMed
  • Published on 5/2/2019

    Martinez L, Verma R, Croda J, Horsburgh CR, Walter KS, Degner N, Middelkoop K, Koch A, Hermans S, Warner D, Wood R, Cobelens F, Andrews JR. Detection, survival and infectious potential of Mycobacterium tuberculosis in the environment: A review of the evidence and epidemiological implications. Eur Respir J. 2019 May 02. PMID: 31048345.

    Read at: PubMed
  • Published on 4/16/2019

    Sinha P, Davis J, Saag L, Wanke C, Salgame P, Mesick J, Horsburgh CR, Hochberg NS. Undernutrition and Tuberculosis: Public Health Implications. J Infect Dis. 2019 Apr 16; 219(9):1356-1363. PMID: 30476125.

    Read at: PubMed
  • Published on 3/27/2019

    Hoyt KJ, Sarkar S, White L, Joseph NM, Salgame P, Lakshminarayanan S, Muthaiah M, Vinod Kumar S, Ellner JJ, Roy G, Horsburgh CR, Hochberg NS. Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis. PLoS One. 2019; 14(3):e0214011. PMID: 30917170.

    Read at: PubMed
  • Published on 3/1/2019

    Berhanu RH, Schnippel K, Kularatne R, Firnhaber C, Jacobson KR, Horsburgh CR, Lippincott CK. Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay. Int J Tuberc Lung Dis. 2019 Mar 01; 23(3):358-362. PMID: 30940300.

    Read at: PubMed
  • Published on 3/1/2019

    Chiang SS, Sheremeta Y, Padilla RS, Jenkins HE, Horsburgh CR, Petrenko V, Rybak NR. Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine. J Epidemiol Glob Health. 2019 Mar; 9(1):56-61. PMID: 30932391.

    Read at: PubMed
  • Published on 2/21/2019

    Freiman JM, Wang J, Easterbrook PJ, Horsburgh CR, Marinucci F, White LF, Kamkamidze G, Krajden M, Loarec A, Njouom R, Nguyen KV, Shiha G, Soliman R, Solomon SS, Tsertsvadze T, Denkinger CM, Linas B. Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset. J Hepatol. 2019 Feb 21. PMID: 30797050.

    Read at: PubMed
  • Published on 2/1/2019

    Reddy KP, Gupta-Wright A, Fielding KL, Costantini S, Zheng A, Corbett EL, Yu L, van Oosterhout JJ, Resch SC, Wilson DP, Horsburgh CR, Wood R, Alufandika-Moyo M, Peters JA, Freedberg KA, Lawn SD, Walensky RP. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. Lancet Glob Health. 2019 Feb; 7(2):e200-e208. PMID: 30683239.

    Read at: PubMed
  • Published on 12/1/2018

    Yuengling KA, Padayatchi N, Wolf A, Mathema B, Brown T, Horsburgh CR, O'Donnell MR. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2018 Dec 01; 79(4):474-480. PMID: 30212394.

    Read at: PubMed
  • Published on 11/27/2018

    Lambert LA, Katz D, Feng PJ, Djojonegoro BM, Fair E, Jasuja S, Marantz S, Horsburgh CR, Ho C. Impact of Choice of Test for Latent Tuberculosis Infection on Treatment Acceptance and Completion. Microbiol Insights. 2018; 11:1178636118811311. PMID: 30505150.

    Read at: PubMed

View 258 more publications: View full profile at BUMC

View all profiles